ATRIP and breast carcinoma: By analyzing the sequence data of the UK Biobank, we identified ATRIP loss of function variants in 13 of 15,643 breast cancer patients and 40 of 157,943 female controls (OR = 3.28, 95% CI = 1.76–6.14, p < 0.001).